project id: TCGA-BRCA; case submitter id: TCGA-AN-A0AK; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.0; rna integrity number: 9.3; spectrophotometer method: UV Spec; age at index: 76; days to birth: -27977; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1934; age at diagnosis: 27977; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 224.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 58; days to sample procurement: 0; initial weight: 290.0; portion submitter id: TCGA-AN-A0AK-01A-21; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 25.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor nuclei: 70.0;